1,1'-Carbonyldiimidazole → 4-(3-(Cyclohexylmethyl)-2-oxo-2,3-dihydro-1H-imidazo[4,5-B]pyrazin-5-YL)benzamide
반응식
Br[C:2]1[N:7]=[C:6]2[N:8]([CH2:12][CH:13]3[CH2:18][CH2:17][CH2:16][CH2:15][CH2:14]3)[C:9](=[O:11])[NH:10][C:5]2=[N:4][CH:3]=1.BrC1N=C([NH:26][CH2:27][CH:28]2[CH2:33][CH2:32][CH2:31][CH2:30][CH2:29]2)C(N)=NC=1.C(N1C=CN=C1)(N1C=CN=C1)=[O:36]>C1COCC1.CN(C=O)C>[CH:13]1([CH2:12][N:8]2[C:6]3[C:5](=[N:4][CH:3]=[C:2]([C:31]4[CH:32]=[CH:33][C:28]([C:27]([NH2:26])=[O:36])=[CH:29][CH:30]=4)[N:7]=3)[NH:10][C:9]2=[O:11])[CH2:18][CH2:17][CH2:16][CH2:15][CH2:14]1참가 물질
6
반응물 3
생성물 1
시약·촉매·용매 2
반응 조건
- 온도
- 120 °C
실험 절차
6-Bromo-1-(cyclohexylmethyl)-1H-imidazo[4,5-b]pyrazin-2(3H)-one. 6-Bromo-N2-(cyclohexylmethyl)pyrazine-2,3-diamine (4.85 g, 17.01 mmol) was dissolved in THF (50 mL), 1,1′-carbonyldiimidazole (3.45 g, 21.26 mmol) was added, and the reaction solution was divided into 4 different vials. Each fraction was heated in a Biotage Emrys Optimizer microwave reactor at 120° C. for 30 min. The reacted fractions were combined and condensed under reduced pressure. The crude material was dissolved in minimal DMF and precipitated with deionized water while sonicating. The filtered product was dried in a vacuum oven at 60° C. over night to afford the title compound (4.72 g, 89%). MS (ESI) m/z 311.3 [M]+, 313.5 [M+2]+
후처리
- customcondensed under reduced pressure
- customprecipitated with deionized water
- customwhile sonicating
- customThe filtered product was dried in a vacuum oven at 60° C. over night
출처 및 근거
- ORD 기록
- ord-8f81d0f7eefd487882cb0c339bbab86b
- 출처 데이터셋
- uspto-grants-2013_02
- 특허 번호
- US08372976B2
반응 노트
불러오는 중…